FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4367396598> ?p ?o ?g. }

• W4367396598 endingPage "100383" @default.
• W4367396598 startingPage "100383" @default.
• W4367396598 abstract "MBOAT7-driven lysophosphatidylinositol acylation in adipocytes contributes to systemic glucose homeostasisJournal of Lipid ResearchVol. 64Issue 4PreviewWe previously demonstrated that antisense oligonucleotide-mediated knockdown of Mboat7, the gene encoding membrane bound O-acyltransferase 7, in the liver and adipose tissue of mice promoted high fat diet-induced hepatic steatosis, hyperinsulinemia, and systemic insulin resistance. Thereafter, other groups showed that hepatocyte-specific genetic deletion of Mboat7 promoted striking fatty liver and NAFLD progression in mice but does not alter insulin sensitivity, suggesting the potential for cell autonomous roles. Full-Text PDF Open Access The Lands cycle, elucidated by Dr William (Bill) Lands, describes the recycling of phospholipids by addition of a fatty acyl chain to a lysophospholipid by lipid acyltransferases and cleavage of a fatty acyl chain to generate a lysophospholipid by phospholipases (1O'Donnell V.B. New appreciation for an old pathway: the Lands Cycle moves into new arenas in health and disease.Biochem. Soc. Trans. 2022; 50: 1-11Crossref PubMed Scopus (4) Google Scholar). Dr Lands published a series of elegant biochemical studies in the late 1950s to mid-1960s (e.g., (2Lands W.E. Metabolism of glycerolipids. 2. The enzymatic acylation of lysolecithin.J. Biol. Chem. 1960; 235: 2233-2237Abstract Full Text PDF PubMed Google Scholar)), describing these processes (Fig. 1). The Lands cycle allows a cell to remodel the acyl chain composition of its membrane phospholipids, and thereby its physical and functional properties (1O'Donnell V.B. New appreciation for an old pathway: the Lands Cycle moves into new arenas in health and disease.Biochem. Soc. Trans. 2022; 50: 1-11Crossref PubMed Scopus (4) Google Scholar). Such remodeling is critical, as recent research demonstrates a role for the Lands cycle in metabolic disease. One of the mammalian lysophospholipid acyltransferases is termed MBOAT7 (membrane bound O-acyltransferase domain containing 7). An updated nomenclature has recently been proposed, which renames MBOAT7 as LPLAT11 (lysophospholipid acyltransferase 11) (5Valentine W.J. Yanagida K. Kawana H. Kono N. Noda N.N. Aoki J. et al.Update and nomenclature proposal for mammalian lysophospholipid acyltransferases, which create membrane phospholipid diversity.J. Biol. Chem. 2022; 298101470Abstract Full Text Full Text PDF PubMed Scopus (22) Google Scholar). MBOAT7 has attracted increased interest in the area of metabolic disease because genome-wide association studies have identified a susceptibility locus (rs641738) within a linkage-disequilibrium block that contains the MBOAT7 gene that associates with liver disease, including nonalcoholic fatty liver disease (6Varadharajan V. Massey W.J. Brown J.M. Membrane-bound O-acyltransferase 7 (MBOAT7)-driven phosphatidylinositol remodeling in advanced liver disease.J. Lipid Res. 2022; 63100234Abstract Full Text Full Text PDF PubMed Scopus (4) Google Scholar). MBOAT7 is highly selective in esterifying lysophosphatidylinositol (LPI) to arachidonoyl-CoA (C20:4-CoA), generating phosphatidylinositol (PI[18:0/20:4]), as shown in Fig. 1. Consistent with the genome-wide association study, silencing MBOAT7 by an antisense oligonucleotide, which resulted in lower MBOAT7 expression primarily in liver, adipose tissue, and cells within the reticuloendothelial system, caused a nonalcoholic fatty liver disease phenotype in fat-fed mice (7Helsley R.N. Varadharajan V. Brown A.L. Gromovsky A.D. Schugar R.C. Ramachandiran I. et al.Obesity-linked suppression of membrane-bound O-acyltransferase 7 (MBOAT7) drives non-alcoholic fatty liver disease.Elife. 2019; 8e49882Crossref PubMed Scopus (53) Google Scholar). Although there were no detected differences in body weights or circulating lipoproteins, MBOAT7 silencing also resulted in insulin resistance, characterized by glucose intolerance, elevated plasma insulin and C-peptide levels, and a reduced ability of insulin to induce insulin receptor β-subunit phosphorylation and downstream Akt phosphorylation in hepatocytes. The dampened insulin action in liver was not observed in adipose tissue, despite an almost similar silencing of MBOAT7 expression in white adipose tissue (WAT) of these mice (7Helsley R.N. Varadharajan V. Brown A.L. Gromovsky A.D. Schugar R.C. Ramachandiran I. et al.Obesity-linked suppression of membrane-bound O-acyltransferase 7 (MBOAT7) drives non-alcoholic fatty liver disease.Elife. 2019; 8e49882Crossref PubMed Scopus (53) Google Scholar). The proposed mechanism was suggested to be due to increased hepatic lipid droplet expansion, but it remained unclear how this mechanism would inhibit insulin’s action. However, when MBOAT7 deletion was subsequently introduced specifically in hepatocytes, the fatty liver phenotype observed in the MBOAT7 antisense oligonucleotide studies above was replicated, but not the insulin resistance (8Xia M. Chandrasekaran P. Rong S. Fu X. Mitsche M.A. Hepatic deletion of Mboat7 (LPIAT1) causes activation of SREBP-1c and fatty liver.J. Lipid Res. 2021; 62100031Abstract Full Text Full Text PDF Google Scholar). One possibility, therefore, was that suppression of MBOAT7 expression in adipose tissue could explain the insulin resistance observed by Helsley and colleagues (7Helsley R.N. Varadharajan V. Brown A.L. Gromovsky A.D. Schugar R.C. Ramachandiran I. et al.Obesity-linked suppression of membrane-bound O-acyltransferase 7 (MBOAT7) drives non-alcoholic fatty liver disease.Elife. 2019; 8e49882Crossref PubMed Scopus (53) Google Scholar). It is in light of these findings that the study by Massey and colleagues (3Massey W.J. Varadharajan V. Banerjee R. Brown A.L. Horak A.J. Hohe R.C. et al.MBOAT7-driven lysophosphatidylinositol acylation in adipocytes contributes to systemic glucose homeostasis.J. Lipid Res. 2023; 64100349https://doi.org/10.1016/j.jlr.2023.100349Abstract Full Text Full Text PDF PubMed Scopus (0) Google Scholar) finds its important context. Having previously demonstrated that hepatic expression of MBOAT7 is suppressed in obese humans and rodents (7Helsley R.N. Varadharajan V. Brown A.L. Gromovsky A.D. Schugar R.C. Ramachandiran I. et al.Obesity-linked suppression of membrane-bound O-acyltransferase 7 (MBOAT7) drives non-alcoholic fatty liver disease.Elife. 2019; 8e49882Crossref PubMed Scopus (53) Google Scholar), that Mboat7 expression in WAT is negatively correlated both with fat pad weight and percent body fat in mice, and that Mboat7 expression in WAT negatively associates with indices of insulin sensitivity, the group confirmed these findings by demonstrating that Mboat7 expression in WAT is negatively correlated with WAT mass in mice fed a high-fat high-sucrose diet, although sex differences were evident in the fat depots affected. To dissect the effects of MBOAT7 in liver and adipose tissue, the group generated adipocyte-targeted and hepatocyte-targeted MBOAT7-deficient mice using Mboat7 floxed mice crossed with adiponectin-Cre and albumin-Cre mice, respectively. Analysis of liver pathology and insulin resistance in these mice revealed that liver-targeted deletion of MBOAT7 resulted in a fatty liver phenotype but not insulin resistance, consistent with previous studies (8Xia M. Chandrasekaran P. Rong S. Fu X. Mitsche M.A. Hepatic deletion of Mboat7 (LPIAT1) causes activation of SREBP-1c and fatty liver.J. Lipid Res. 2021; 62100031Abstract Full Text Full Text PDF Google Scholar). Conversely, although fasting plasma insulin levels were elevated in fat-fed mice lacking MBOAT7 in hepatocytes, deletion of MBOAT7 in adipocytes caused hyperinsulinemia and reduced insulin sensitivity, with only minor effects on the liver fat. Thus, the insulin resistance phenotype appears to be largely selective to loss of MBOAT7 in adipocytes. Interestingly, MBOAT7 is downregulated by acute injection of insulin in both liver and adipose tissue (4Meroni M. Dongiovanni P. Longo M. Carli F. Baselli G. Rametta R. et al.Mboat7 down-regulation by hyper-insulinemia induces fat accumulation in hepatocytes.EBioMedicine. 2020; 52102658Abstract Full Text Full Text PDF PubMed Scopus (48) Google Scholar), suggesting the possibility that hyperinsulinemia might worsen systemic insulin resistance through downregulation of MBOAT7. The study by Massey and colleagues (3Massey W.J. Varadharajan V. Banerjee R. Brown A.L. Horak A.J. Hohe R.C. et al.MBOAT7-driven lysophosphatidylinositol acylation in adipocytes contributes to systemic glucose homeostasis.J. Lipid Res. 2023; 64100349https://doi.org/10.1016/j.jlr.2023.100349Abstract Full Text Full Text PDF PubMed Scopus (0) Google Scholar) raises many intriguing questions, including questions on the mechanism whereby adipocyte MBOAT7-deficiency worsens insulin resistance in fat-fed mice and whether the insulin resistance phenotype in adipocyte-targeted MBOAT7-deficient mice is due to adipocyte insulin resistance. To start to address the latter question, the authors performed hyperinsulinemic-euglycemic clamps. These studies indicated that the insulin resistance in adipocyte-targeted MBOAT7-deficient mice likely is due to autocrine or paracrine mechanisms leading to insulin resistance in the adipose tissue rather than in the liver or other insulin target tissues. Massey further showed that MBOAT7 deficiency results in a marked reduction in PI species containing arachidonoyl-acyl chains, primarily PI(18:0/20:4), and increased levels of 18:0-LPI and 18:1-LPI in WAT (Fig. 1). But how would these changes lead to insulin resistance? Is it possible that reduced PI biosynthesis through the Lands cycle could lead to reduced insulin signaling through phosphatidylinositol phosphate kinases? Could altered levels of protein lipid anchors through glycosylphosphatidylinositol be an explanation? Answers to these questions await further research, as pointed out by the authors. In the meantime, several potential mechanisms mediated by changes in specific lipid species in WAT were ruled out by Massey et al. (3Massey W.J. Varadharajan V. Banerjee R. Brown A.L. Horak A.J. Hohe R.C. et al.MBOAT7-driven lysophosphatidylinositol acylation in adipocytes contributes to systemic glucose homeostasis.J. Lipid Res. 2023; 64100349https://doi.org/10.1016/j.jlr.2023.100349Abstract Full Text Full Text PDF PubMed Scopus (0) Google Scholar). A comprehensive lipidomics analysis of WAT showed that other than a few alterations in phospholipids containing polyunsaturated acyl-chains, changes of free fatty acids, non-LPI lysophospholipids, phosphatidylcholines, sphingomyelins, ceramides, triacylglycerols, diacylglycerols, or oxylipins were unlikely to explain the increased insulin resistance. Moreover, plasma nonesterified fatty acid levels did not appear to be increased in mice with adipocyte-selective MBOAT7 deficiency, suggesting that increased adipocyte lipolysis did not explain systemic insulin resistance. There were no significant differences in liver or plasma levels of PI or LPI lipid species in mice lacking MBOAT7 in adipocytes, pointing to a local adipose tissue mechanism. To test if LPI indeed affects insulin signaling in WAT, mice with and without adipose MBOAT7 deficiency were injected with 18:1-LPI and the gonadal WAT global phosphoproteome was analyzed. Pathway enrichment analysis showed increased insulin signaling and insulin resistance signatures in the LPI-injected MBOAT7-deficient mice. Although direct measurements of insulin-induced Akt and PI3K activities in WAT were not done in the current study, these results support the authors’ conclusion that accumulation of LPI locally in adipose tissue alters insulin signaling in an MBOAT7-dependent manner. Still, the mechanism whereby this occurs largely remains a black box mystery (Fig. 1). In addition to the mechanisms discussed above, a possibility may be that the increased adipose tissue inflammation (3Massey W.J. Varadharajan V. Banerjee R. Brown A.L. Horak A.J. Hohe R.C. et al.MBOAT7-driven lysophosphatidylinositol acylation in adipocytes contributes to systemic glucose homeostasis.J. Lipid Res. 2023; 64100349https://doi.org/10.1016/j.jlr.2023.100349Abstract Full Text Full Text PDF PubMed Scopus (0) Google Scholar), including a Cd11c-/Cd206+ cell population (an adipose tissue macrophage population expressing scavenger receptors in humans; (9Muir L.A. Cho K.W. Geletka L.M. Baker N.A. Flesher C.G. Ehlers A.P. et al.Human CD206+ macrophages associate with diabetes and adipose tissue lymphoid clusters.JCI Insight. 2022; 7e146563Crossref PubMed Scopus (10) Google Scholar)) and a reciprocal decrease in Cd11c+/Cd206+ double-positive cells (an antigen-presenting lipid-loaded adipose tissue macrophage population in humans; (9Muir L.A. Cho K.W. Geletka L.M. Baker N.A. Flesher C.G. Ehlers A.P. et al.Human CD206+ macrophages associate with diabetes and adipose tissue lymphoid clusters.JCI Insight. 2022; 7e146563Crossref PubMed Scopus (10) Google Scholar)), and higher numbers of T and B cells could contribute to insulin resistance. A causal relationship between adipose tissue macrophages and systemic insulin resistance has been shown by others (10Cao S. Pan Y. Tang J. Terker A.S. Arroyo Ornelas J.P. Jin G.N. et al.EGFR-mediated activation of adipose tissue macrophages promotes obesity and insulin resistance.Nat. Commun. 2022; 13: 4684Crossref PubMed Scopus (7) Google Scholar). Such effects might potentially be mediated by the LPI receptor GPR55, which has been suggested to promote inflammatory activation of macrophages in response to LPI (11Kurano M. Kobayashi T. Sakai E. Tsukamoto K. Yatomi Y. Lysophosphatidylinositol, especially albumin-bound form, induces inflammatory cytokines in macrophages.FASEB J. 2021; 35e21673Crossref PubMed Scopus (16) Google Scholar), through a paracrine effect of LPI released from adipocytes locally in the adipose tissue depot. Undoubtedly, the study by Massey and colleagues will inspire more research into the mechanisms whereby MBOAT7 and PI biosynthesis through the Lands cycle protect against liver disease, adipose tissue inflammation, insulin resistance, and potentially diabetes. K.E.B. serves on the scientific advisory board of Esperion Therapeutics, Inc. K. E. B. is responsible for all aspects of this article. Work in K. E. B.’s laboratory is supported by grants from the National Institutes of Health P01HL151328, R01HL149685, and R35HL150754. The content is solely the responsibility of the author and does not necessarily represent the official views of the National Institutes of Health." @default.
• W4367396598 created "2023-04-30" @default.
• W4367396598 creator A5011658040 @default.
• W4367396598 date "2023-06-01" @default.
• W4367396598 modified "2023-10-14" @default.
• W4367396598 title "Adipocyte phosphatidylinositol biosynthesis via the Lands cycle protects against insulin resistance" @default.
• W4367396598 cites W2427396309 @default.
• W4367396598 cites W2981129394 @default.
• W4367396598 cites W3006029231 @default.
• W4367396598 cites W3082989514 @default.
• W4367396598 cites W3165244426 @default.
• W4367396598 cites W4200272435 @default.
• W4367396598 cites W4206170515 @default.
• W4367396598 cites W4214490437 @default.
• W4367396598 cites W4281700583 @default.
• W4367396598 cites W4291021660 @default.
• W4367396598 cites W4321349230 @default.
• W4367396598 doi "https://doi.org/10.1016/j.jlr.2023.100383" @default.
• W4367396598 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37127068" @default.
• W4367396598 hasPublicationYear "2023" @default.
• W4367396598 type Work @default.
• W4367396598 citedByCount "0" @default.
• W4367396598 crossrefType "journal-article" @default.
• W4367396598 hasAuthorship W4367396598A5011658040 @default.
• W4367396598 hasBestOaLocation W43673965981 @default.
• W4367396598 hasConcept C134018914 @default.
• W4367396598 hasConcept C171089720 @default.
• W4367396598 hasConcept C181199279 @default.
• W4367396598 hasConcept C185592680 @default.
• W4367396598 hasConcept C2776175234 @default.
• W4367396598 hasConcept C2777391703 @default.
• W4367396598 hasConcept C2779306644 @default.
• W4367396598 hasConcept C2780610907 @default.
• W4367396598 hasConcept C553450214 @default.
• W4367396598 hasConcept C55493867 @default.
• W4367396598 hasConcept C62478195 @default.
• W4367396598 hasConcept C86803240 @default.
• W4367396598 hasConcept C95444343 @default.
• W4367396598 hasConceptScore W4367396598C134018914 @default.
• W4367396598 hasConceptScore W4367396598C171089720 @default.
• W4367396598 hasConceptScore W4367396598C181199279 @default.
• W4367396598 hasConceptScore W4367396598C185592680 @default.
• W4367396598 hasConceptScore W4367396598C2776175234 @default.
• W4367396598 hasConceptScore W4367396598C2777391703 @default.
• W4367396598 hasConceptScore W4367396598C2779306644 @default.
• W4367396598 hasConceptScore W4367396598C2780610907 @default.
• W4367396598 hasConceptScore W4367396598C553450214 @default.
• W4367396598 hasConceptScore W4367396598C55493867 @default.
• W4367396598 hasConceptScore W4367396598C62478195 @default.
• W4367396598 hasConceptScore W4367396598C86803240 @default.
• W4367396598 hasConceptScore W4367396598C95444343 @default.
• W4367396598 hasFunder F4320332161 @default.
• W4367396598 hasFunder F4320337338 @default.
• W4367396598 hasIssue "6" @default.
• W4367396598 hasLocation W43673965981 @default.
• W4367396598 hasLocation W43673965982 @default.
• W4367396598 hasLocation W43673965983 @default.
• W4367396598 hasOpenAccess W4367396598 @default.
• W4367396598 hasPrimaryLocation W43673965981 @default.
• W4367396598 hasRelatedWork W2003112034 @default.
• W4367396598 hasRelatedWork W2016057096 @default.
• W4367396598 hasRelatedWork W2089400978 @default.
• W4367396598 hasRelatedWork W2099789512 @default.
• W4367396598 hasRelatedWork W2102605166 @default.
• W4367396598 hasRelatedWork W2106310612 @default.
• W4367396598 hasRelatedWork W2131302372 @default.
• W4367396598 hasRelatedWork W2341781836 @default.
• W4367396598 hasRelatedWork W2410789767 @default.
• W4367396598 hasRelatedWork W3118045786 @default.
• W4367396598 hasVolume "64" @default.
• W4367396598 isParatext "false" @default.
• W4367396598 isRetracted "false" @default.
• W4367396598 workType "article" @default.